Ernest Little, MD
Neurology · Shreveport, LANPI 1780779199
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $38,469 of the $52,042 with a category attached, or 73.9%. 13 manufacturers reported payments, led by Sanofi at 49.3% of the total. Reporting peaked in 2019 at $19,517 and has fallen 99.0% since, to $204 in 2025. Among neurology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $468.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$26K
- AstraZeneca$18K
- Amgen$7K
- Avanir Pharmaceuticals, Inc.$273
- Johnson & Johnson$215
- Silk Road Medical, Inc.$165
- plus $501 from 7 others
What the payments were for
- Consulting fees$4,4809%
- Speaking & faculty fees$38,46974%
- Travel & lodging$4,6069%
- Food & beverage$4,4879%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 36 | $25,663 |
| AstraZeneca(2 entities) | 27 | $17,928 |
| Amgen(2 entities) | 26 | $7,296 |
| Avanir Pharmaceuticals, Inc. | 4 | $273 |
| Johnson & Johnson | 7 | $215 |
| Silk Road Medical, Inc. | 2 | $165 |
| Portola Pharmaceuticals, LLC | 2 | $152 |
| Biohaven Pharmaceuticals, Inc. | 2 | $149 |
| Medtronic | 1 | $125 |
| TG Therapeutics, Inc. | 1 | $26 |
| Biogen | 1 | $24 |
| Genentech USA, Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUBAGIO$24,907
- ANDEXXA$16,833
- UPLIZNA$6,711
- ULTOMIRIS$560
- NUEDEXTA$251
- SOLIRIS$249
- ENROUTE Transcarotid Neuroprotection System$125
- ENROUTE Transcarotid Stent System$125
- ENHANCE Transcarotid Peripheral Access Kit$125
- ENROUTE 0.014 Guidewire$125
- NURTEC ODT$125
- LINQ II$125
- XARELTO$110
How this compares
$52,042 in reported general payments places this provider in the 90th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Shreveport
- Meghan HarrisShreveport$553K
- Erik BurtonShreveport$154K
- Chaitanya AmrutkarShreveport$17K
- Debra DavisShreveport$16K
- Jenny GuerreShreveport$15K
- Gurleen SikandShreveport$14K
- Kevin CallerameBaton Rouge$420K
- Gerald CaleganBaton Rouge$400K
- Maria Carmen WilsonCovington$295K
- John EnglandNew Orleans$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.